Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Aplastic Anemia”

203 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 203 results

Not applicableStudy completedNCT00521430
What this trial is testing

Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Asan Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00004464
What this trial is testing

Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria

Who this might be right for
Aplastic AnemiaParoxysmal Hemoglobinuria, Nocturnal
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 69
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05419843
What this trial is testing

Up-front Matched Unrelated Donor Transplantation in Pediatric Patients With Idiopathic Aplastic Anemia

Who this might be right for
Idiopathic Aplastic AnemiaSevere Aplastic AnemiaModerate Aplastic Anemia Requiring Transfusions
Assistance Publique - Hôpitaux de Paris 25
Large-scale testing (Phase 3)Not Yet RecruitingNCT07345000
What this trial is testing

Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe Aplastic Anemia

Who this might be right for
Treatment-naïve Severe Aplastic Anemia
Qilu Pharmaceutical Co., Ltd. 210
Early research (Phase 1)UnknownNCT03836690
What this trial is testing

Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation

Who this might be right for
LymphomaLeukemiaMyeloma+4 more
University College, London 18
Post-approval studies (Phase 4)Not Yet RecruitingNCT06426043
What this trial is testing

A Prospective Study on the Treatment of Recurrent/Refractory/Intolerable NSAA With Lusutrombopag

Who this might be right for
Aplastic Anemia
Peking Union Medical College Hospital 40
Testing effectiveness (Phase 2)Study completedNCT01187017
What this trial is testing

A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia

Who this might be right for
Aplastic AnemiaNeutropeniaPancytopenia+1 more
National Heart, Lung, and Blood Institute (NHLBI) 1
Testing effectiveness (Phase 2)UnknownNCT02407470
What this trial is testing

Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia

Who this might be right for
Severe Aplastic Anemia
Navy General Hospital, Beijing 90
Not applicableStudy completedNCT01768845
What this trial is testing

Unrelated Umbilical Cord Blood (UBC)Transplantation

Who this might be right for
Chronic Myelogenous Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome+6 more
West Virginia University 34
Early research (Phase 1)Study completedNCT00578266
What this trial is testing

Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia

Who this might be right for
Anemia, Aplastic
Mayo Clinic 8
Testing effectiveness (Phase 2)Study completedNCT02797977
What this trial is testing

A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects

Who this might be right for
Advanced Solid Tumors
Sierra Oncology LLC - a GSK company 153
Testing effectiveness (Phase 2)Study completedNCT03025698
What this trial is testing

A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia

Who this might be right for
Aplastic Anemia
Novartis Pharmaceuticals 51
Testing effectiveness (Phase 2)Study completedNCT00301834
What this trial is testing

Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders

Who this might be right for
Congenital Amegakaryocytic ThrombocytopeniaDiamond-blackfan AnemiaLeukemia+2 more
University of California, San Francisco 35
Not applicableActive Not RecruitingNCT01199562
What this trial is testing

Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant

Who this might be right for
Hematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated Leukemia+151 more
City of Hope Medical Center 153
Not applicableEnded earlyNCT02179359
What this trial is testing

Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies

Who this might be right for
Sickle Cell DiseaseTransfusion Dependent Alpha- or Beta- ThalassemiaDiamond Blackfan Anemia+5 more
Masonic Cancer Center, University of Minnesota 38
Not applicableStudy completedNCT00186797
What this trial is testing

Purified CD34+ Hematopoietic Stem Cell Transplantation From Alternate Donors for Patients With Severe Aplastic Anemia

Who this might be right for
Aplastic Anemia
St. Jude Children's Research Hospital 28
Testing effectiveness (Phase 2)Study completedNCT00195624
What this trial is testing

Alemtuzumab to Treat Severe Aplastic Anemia

Who this might be right for
Severe Aplastic Anemia, RefractorySevere Aplastic Anemia, Relapse
National Heart, Lung, and Blood Institute (NHLBI) 47
Very early researchLooking for participantsNCT06633328
What this trial is testing

CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia

Who this might be right for
Aplastic Anemia
Zhejiang University 30
Testing effectiveness (Phase 2)Study completedNCT01703169
What this trial is testing

Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic Anemia

Who this might be right for
Severe Aplastic AnemiaVery Severe Aplastic AnemiaModerate Aplastic Anemia
University of Utah 13
Testing effectiveness (Phase 2)Study completedNCT00343785
What this trial is testing

Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Marrow Transplant

Who this might be right for
Aplastic Anemia
Fred Hutchinson Cancer Center 21
Load More Results